Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Dr. Gary Lawton Yale-Trained Plastic Surgeon: New Non-Opioid Pain Medication for Recovery Protocols

      Lawton Plastic Surgery

      News provided by

      LAWTON PLASTIC SURGERY

      Jul 28, 2026, 19:31 ET

      Share this article

      Share this article


      After more than 25 years in practice and tens of thousands of breast and body procedures, Dr. Gary Lawton reports encouraging early clinical experience using JOURNAVX® as part of an advanced multimodal recovery protocol for his cosmetic surgery patients.

      SAN ANTONIO, July 28, 2026 /PRNewswire/ -- For patients considering breast augmentation, breast lift or reduction, implant revision surgery, tummy tuck, liposuction, or a combined mommy makeover, postoperative recovery has long been one of the biggest concerns. Dr. Gary Lawton, a board-certified plastic surgeon in San Antonio who has devoted more than 25 years exclusively to cosmetic surgery of the breast and body and has performed tens of thousands of procedures during that time, believes that this is starting to change.

      Dr. Lawton has incorporated JOURNAVX® (suzetrigine) — the first FDA-approved medication in a new, non-opioid drug class — into his postoperative pain management protocol for tummy tuck patients, including those undergoing tummy tucks as part of a combined mommy makeover with breast augmentation, breast lift, breast reduction, or implant revision surgery.

      Approved by the U.S. Food and Drug Administration in January 2025, JOURNAVX is the first approved medication that selectively targets NaV1.8 pain-signaling sodium channels in the peripheral nervous system. Unlike opioids, it does not activate opioid receptors and was developed to treat moderate-to-severe acute pain while reducing reliance on narcotic medications. JOURNAVX was evaluated in randomized clinical trials involving patients undergoing full abdominoplasty, the procedure at the core of both standalone tummy tucks and most mommy makeovers.

      "During more than two decades performing cosmetic surgery of the breast and body, I have evaluated virtually every advancement in postoperative pain management," said Dr. Lawton. "Many improvements have been incremental. The introduction of an entirely new mechanism for treating acute postoperative pain is genuinely different — and it matters most for our bigger cases, like tummy tuck and full mommy makeover, where recovery comfort has always been the top question patients ask me."

      Dr. Lawton reports that patients receiving JOURNAVX as part of a comprehensive multimodal recovery protocol have experienced excellent postoperative comfort, requiring fewer rescue narcotic medications than historically expected, along with smoother early recovery and a more rapid return to normal postoperative milestones.

      "Patients consistently tell us they are surprised by how little pain they feel after surgery," Dr. Lawton said. "Anything that allows us to decrease reliance on opioids while maintaining excellent pain control represents meaningful progress — for breast augmentation recovery, tummy tuck recovery, liposuction recovery, and especially for mommy makeover patients managing both surgery of the breast and body at once."

      At Lawton Plastic Surgery, one of the nation's high-volume cosmetic breast and body surgery practices, Dr. Lawton believes real-world clinical outcomes from experienced surgeons will play an important role in defining how this new class of medication is incorporated into modern recovery protocols across the full range of body-contouring and breast procedures.

      "Our philosophy has always been continuous improvement," Dr. Lawton said. "Every refinement, whether surgical, anesthetic, or advanced postoperative wound healing protocol, is made for one reason: to improve the patient experience. We are excited to continue evaluating how first-in-class non-opioid therapies can further advance recovery after cosmetic surgery."

      Dr. Lawton plans to prospectively evaluate patient-reported outcomes, postoperative pain scores, opioid rescue medication use, and recovery milestones as additional patients are treated using the updated protocol.

      With opioid stewardship becoming an increasingly important priority across medicine, the adoption of innovative non-opioid therapies may help reshape postoperative recovery for cosmetic surgery patients, whether they are undergoing breast augmentation, breast lift, breast reduction, implant revision surgery, tummy tuck, liposuction, or a combined breast and body mommy makeover, while maintaining the highest standards of comfort patients expect.

      Media Contact:

      Contact

      Dr. Gary Lawton

      Lawton Plastic Surgery

      525 Oak Centre Drive, Suite 260

      San Antonio, Texas

      (210) 496-2639

      https://www.plasticsurgery-sanantonio.com/contact-us/map-and-directions

      About Dr. Gary Lawton

      Dr. Gary Lawton is a Board-Certified, American Society of Plastic Surgeons 25-Year Milestone-Recognized Cosmetic Plastic Surgeon in San Antonio, Texas. Dr. Lawton is fully Yale-trained in both General and Plastic Surgery, and spent an additional two years completing a Yale Wound Healing Laboratory Fellowship where he performed bench-level scientific research on the biology of wound healing. Dr. Lawton is a Scene in SA Top SA Surgeon, and a RealSelf TOP 100 Hall of Fame Distinguished Inductee who has devoted more than 25 years exclusively to cosmetic surgery of the breast and body, including breast augmentation, breast lift, breast reduction, tummy tuck, liposuction, and mommy makeover. He has performed tens of thousands of procedures in his own private QUAD A Accredited Class C certified outpatient surgery facility in the Stone Oak area of San Antonio. Dr. Lawton has spent more than twenty-five years refining every aspect of cosmetic breast and body surgery through evidence-based innovation, meticulous surgical technique, advanced wound-healing principles, and the continual refinement of patient recovery protocols.

      SOURCE LAWTON PLASTIC SURGERY

      Modal title

      Also from this source

      Dr. Gary Lawton: Surgeon Selection Prevents Implant Revision Failure

      Dr. Gary Lawton: Surgeon Selection Prevents Implant Revision Failure

      Choosing the right surgeon can determine whether a complex breast implant revision produces a durable correction or another failed result. Breast...

      Dr. Gary Lawton: Hidden Risks of Combining Liposuction With a Tummy Tuck

      Dr. Gary Lawton: Hidden Risks of Combining Liposuction With a Tummy Tuck

      Combining a tummy tuck with abdominal, flank or circumferential liposuction is frequently marketed as a convenient way to obtain more dramatic...

      More Releases From This Source

      Explore

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Cosmetics and Personal Care

      Cosmetics and Personal Care

      New Products & Services

      New Products & Services

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.